Dr. Timothy Bailey, MD, the Institute’s director, said, “There are a number of medications being used by people with type 2 diabetes that do not adequately control their blood sugar levels. This new study will help determine if an investigational medication can help these people provide better control of their blood glucose.”
The study will compare the effectiveness of the investigational medicine for people using prescription medications such as Lantus®, Levemir®, Humulin®N, or Novolin®N with or without metformin and/or Actos®.
Qualified participants will receive study-related medical evaluations and medication at no cost, and may be compensated for their time and travel. Participants must be at least 18 years old.
For more information and to volunteer for this study, contact AMCR Institute at 877-567-2627.
# # #
About AMCR Institute: With clinics in Escondido and Temecula, California, AMCR Institute is a clinical research center engaged in trials in the fields of endocrinology and metabolism, focusing on type 1 and type 2 diabetes, lipids, and men’s and women’s health issues. For information call 877-567-2627 or visit http://www.amcrinstitute.com.